Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials
Author:
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2011.10629.x/fullpdf
Reference40 articles.
1. Immunotherapy for advanced renal cell cancer;Coppin;Cochrane Database Syst Rev,2000
2. The genetic basis of kidney cancer: a metabolic disease;Linehan;Nat Rev Urol,2010
3. Targeted therapy for advanced renal cell carcinoma;Coppin;Cochrane Database Syst Rev,2008
4. Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma - CALGB 69901;Stadler;J Clin Oncol,2005
5. Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma;Ratain;J Clin Oncol,2006
Cited by 233 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A novel immune-related lncRNA signature predicts the prognosis and immune landscape in ccRCC;Aging;2024-03-13
2. A network meta-analysis evaluating the efficacy and safety of adjuvant therapy after nephrectomy in renal cell carcinoma;BMC Urology;2024-03-07
3. STX4 as a potential biomarker for predicting prognosis and guiding clinical treatment decisions in clear cell renal cell carcinoma;Heliyon;2024-01
4. Biotargeting in Metastatic Bone Disease;Metastatic Bone Disease;2024
5. STAT3 phosphorylation at serine 727 activates specific genetic programs and promotes clear cell renal cell carcinoma (ccRCC) aggressiveness;Scientific Reports;2023-11-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3